Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 4301 (106th)

To amend the Federal Food, Drug, and Cosmetic Act relating to the distribution chain of prescription drugs.

referredUnited States· United States Congress· EN

Introduced

13 April 2000

Last action

24 April 2000 · Referred

Status

Referred to the Subcommittee on Health and Environment.

Sponsors

Rep. Emerson, Jo Ann [R-MO-8], Rep. Berry, Marion [D-AR-1], Rep. Burton, Dan [R-IN-5], Rep. Wexler, Robert [D-FL-19], Rep. Sherman, Brad [D-CA-32], Rep. Hall, Tony P. [D-OH-3], Rep. Ehrlich, Robert L., Jr. [R-MD-2], Rep. Whitfield, Ed [R-KY-1], Rep. Paul, Ron [R-TX-14], Rep. Gordon, Bart [D-TN-6], Rep. Boehner, John A. [R-OH-8], Rep. Ewing, Thomas W. [R-IL-15], Rep. Lee, Barbara [D-CA-12], Rep. Calvert, Ken [R-CA-41], Rep. Slaughter, Louise McIntosh [D-NY-25], Rep. Stark, Fortney Pete [D-CA-13], Rep. Tancredo, Thomas G. [R-CO-6], Rep. Goode, Virgil H., Jr. [R-VA-5], Rep. Hall, Ralph M. [R-TX-4], Rep. Allen, Thomas H. [D-ME-1], Sen. Sununu, John E. [R-NH], Rep. Andrews, Robert E. [D-NJ-1], Rep. Baldacci, John Elias [D-ME-2], Rep. Dingell, John D. [D-MI-12], Rep. Price, David E. [D-NC-4], Rep. Tiahrt, Todd [R-KS-4], Rep. Souder, Mark E. [R-IN-3], Rep. Doyle, Michael F. [D-PA-14], Rep. Stenholm, Charles W. [D-TX-17], Rep. Clement, Bob [D-TN-5], Rep. Diaz-Balart, Lincoln [R-FL-21], Rep. Turner, Jim [D-TX-2], Rep. Boyd, Allen [D-FL-2], Rep. Klink, Ron [D-PA-4], Rep. Bachus, Spencer [R-AL-6], Rep. Sandlin, Max [D-TX-1], Rep. Deal, Nathan [R-GA-9], Rep. Shimkus, John [R-IL-15], Rep. Roukema, Marge [R-NJ-5], Rep. Weldon, Dave [R-FL-15], Rep. Bentsen, Ken [D-TX-25]

Subjects

Healthcare

Source updated

3 June 2026

Healthcare

Official sourceDownload fileView documentsShare

Summary

Amends the Federal Food, Drug, and Cosmetic Act to require the wholesale distributor of certain drugs who is not the manufacturer or an authorized distributor of record for a calendar year (currently, the language "for a calendar year" is not in the Act) of a drug to provide to the recipient of the drug a statement identifying each prior sale, purchase, or trade of such drug.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 13 April 2000

    Introduced

    Referred to the House Committee on Commerce.

    Source: IntroReferral

  2. 13 April 2000

    Introduced

    Sponsor introductory remarks on measure. (CR E586)

    Source: IntroReferral

  3. 13 April 2000

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 13 April 2000

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 24 April 2000

    Referred

    Referred to the Subcommittee on Health and Environment.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 13 April 2000

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 13 April 2000

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 13 April 2000

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.